Related Experiment Videos

Thrombolytic therapy in acute myocardial infarction

N U Bang¹, O G Wilhelm, M D Clayman

¹Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.

Annual Review of Pharmacology and Toxicology

|January 1, 1989

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Antithrombotic agents from salivary glands of hematophagous animals.

Trends in cardiovascular medicine·2011

The uPA/uPA receptor system as a target for tumor therapy.

Drug news & perspectives·2003

Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke.

Neuroscience letters·2001

Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).

Biological chemistry·2001

High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice.

Biological chemistry·2001

Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.

American journal of hematology·2000

See all related articles